Neoleukin Therapeutics, Inc.·5

Feb 14, 7:54 PM ET

DRACHMAN JONATHAN G 5

5 · Neoleukin Therapeutics, Inc. · Filed Feb 14, 2022

Insider Transaction Report

Form 5
Period: 2021-12-31
DRACHMAN JONATHAN G
DirectorPresident and CEO
Transactions
  • Gift

    Common Stock

    2021-10-26+75,000100,000 total(indirect: See footnote)
  • Gift

    Common Stock

    2021-10-26+75,000100,000 total(indirect: See footnote)
  • Gift

    Common Stock

    2021-10-2675,0002,198,686 total
  • Gift

    Common Stock

    2021-10-2675,0002,198,686 total
Footnotes (2)
  • [F1]These securities are held by the PLD Family Trust 2020.
  • [F2]These securities are held by the JGD Family Trust 2020.

Documents

2 files
  • 5
    doc5.xmlPrimary

    FORM 5 SUBMISSION

  • EX-24

    POA DOCUMENT